Gene · 200315
Papers1,983
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,983
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mutational processes of tobacco smoking and APOBEC activity generate protein-truncating mutations in cancer genomes. | Sci Adv | 2023 | 37922356 | PubTator, text mining | PubMed |
| Causal identification of single-cell experimental perturbation effects with CINEMA-OT. | Nat Methods | 2023 | 37919419 | PubTator, text mining | PubMed |
| Seven chromatin regulators as immune cell infiltration characteristics, potential diagnostic biomarkers and drugs prediction in hepatocellular carcinoma. | Sci Rep | 2023 | 37903974 | PubTator, text mining | PubMed |
| Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers. | Int J Mol Sci | 2023 | 37894756 | PubTator, text mining | PubMed |
| Virally encoded interleukin-6 facilitates KSHV replication in monocytes and induction of dysfunctional macrophages. | PLoS Pathog | 2023 | 37883374 | PubTator, text mining | PubMed |
| Whole genome methylation sequencing reveals epigenetic landscape and abnormal expression of FABP5 in extramammary Paget's disease. | Skin Res Technol | 2023 | 37881057 | PubTator, text mining | PubMed |
| Differential RNA editing landscapes in host cell versus the SARS-CoV-2 genome. | iScience | 2023 | 37876814 | PubTator, text mining | PubMed |
| Familial Risk and Interaction With Smoking and Alcohol Consumption in Bladder Cancer: A Population-Based Cohort Study. | World J Oncol | 2023 | 37869241 | PubTator, text mining | PubMed |
| Molecular genetic aberrations in the pathogenesis of multiple myeloma. | Asian Biomed (Res Rev News) | 2023 | 37860676 | PubTator, text mining | PubMed |
| Artificial intelligence and the analysis of cryo-EM data provide structural insight into the molecular mechanisms underlying LN-lamininopathies. | Sci Rep | 2023 | 37857770 | PubTator, text mining | PubMed |
| Engineering of cytosine base editors with DNA damage minimization and editing scope diversification. | Nucleic Acids Res | 2023 | 37843111 | PubTator, text mining | PubMed |
| Structure-guided inhibition of the cancer DNA-mutating enzyme APOBEC3A. | Nat Commun | 2023 | 37821454 | PubTator, text mining | PubMed |
| Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell Carcinoma. | Cancer Res Commun | 2023 | 37819239 | PubTator, text mining | PubMed |
| The role of APOBEC3C in modulating the tumor microenvironment and stemness properties of glioma: evidence from pancancer analysis. | Front Immunol | 2023 | 37809064 | PubTator, text mining | PubMed |
| Expanded palette of RNA base editors for comprehensive RBP-RNA interactome studies. | bioRxiv | 2023 | 37808757 | PubTator, text mining | PubMed |
| Human APOBEC3B promotes tumor development in vivo including signature mutations and metastases. | Cell Rep Med | 2023 | 37797615 | PubTator, text mining | PubMed |
| Learning single-cell perturbation responses using neural optimal transport. | Nat Methods | 2023 | 37770709 | PubTator, text mining | PubMed |
| Multimodal analysis of cell-free DNA whole-methylome sequencing for cancer detection and localization. | Nat Commun | 2023 | 37758728 | PubTator, text mining | PubMed |
| Cancer-Associated Fibroblast-Induced Remodeling of Tumor Microenvironment in Recurrent Bladder Cancer. | Adv Sci (Weinh) | 2023 | 37743226 | PubTator, text mining | PubMed |
| APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer. | Nat Genet | 2023 | 37735199 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/200315/papers?page=10